Mon, 07 Jul 2025 13:59:00 -0400

​Darzalex SC (injection de daratumumab) est indiqué en association avec le bortézomib, le lénalidomide et la dexaméthasone dans le traitement du myélome multiple nouvellement diagnostiqué chez l'adulte qui ne reçoit pas de greffe autologue de cellules souches comme traitement initial.

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program

The FDA is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD) - including certain formulations of amphetamine and methylphenidate - to warn about the risk of weight loss and other adverse reactions (side effects) in patients yo

Sandoz, Inc. (“Sandoz”) is initiating a voluntary recall of one (1) lot of Cefazolin for Injection, USP, 1 gram per vial.